Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 87Leukemia 83Leukemia, Myeloid, Acute 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 62Lymphoma 58Leukemia, Lymphocytic, Chronic, B-Cell 57Lymphoma, Non-Hodgkin 53Multiple Myeloma 50Hodgkin Disease 47Myeloproliferative Disorders 45Leukemia, Myeloid, Chronic-Phase 41Lymphoma, Follicular 39Leukemia, Myeloid, Accelerated Phase 39Lymphoma, Mantle-Cell 38Lymphoma, Large B-Cell, Diffuse 38Lymphoma, B-Cell, Marginal Zone 38Burkitt Lymphoma 36Neoplasms, Plasma Cell 33Congenital Abnormalities 33Lymphoma, Large-Cell, Immunoblastic 31Primary Myelofibrosis 28Graft vs Host Disease 28Blast Crisis 28Leukemia, Myelomonocytic, Chronic 27Myelodysplastic-Myeloproliferative Diseases 24Dendritic Cell Sarcoma, Interdigitating 24Anemia, Refractory, with Excess of Blasts 24Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Standard of Care 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metabolism, Inborn Errors × Antilymphocyte Serum × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡